Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study
David Hillus(Erasmus MC), Caroline Isner(Auguste-Viktoria-Klinik), N. Stobäus(Humboldt-Universität zu Berlin), Antonio Losa Carmona(Aetion (United States)), Anja Potthoff(Ruhr University Bochum), Hartmut Stocker(Auguste-Viktoria-Klinik), Thomas Wünsche(Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer), Marcel Lee(TUM Klinikum), Markus Bickel(KPMG (United Kingdom)), Pinkus Tober‐Lau(Charité - Universitätsmedizin Berlin), Regina Stegherr(Humboldt-Universität zu Berlin), Hubert Schulbin(Orthopädische Praxis), Ran D. Balicer(Ben-Gurion University of the Negev), Anne‐Katrin Fietz(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Christoph Wyen, Ngoc Han Le(Humboldt-Universität zu Berlin), Gal Goldstein(Hadassah Medical Center), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Christiane Cordes(Klinikum im Friedrichshain), Bethany Knox(Universitat Pompeu Fabra), Axel Baumgarten, M. Vallée(Praxis), Florian Voit(Technical University of Munich), Ulrich Bohr
Cited by 26
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients
|Infection|2020|246
A time-resolved proteomic and prognostic map of COVID-19
|Cell Systems|2021|222